VANCOUVER, BC, Nov. 5, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and ...

New York State’s stockpile of antiviral medications for flu contains only one drug, Tamiflu, leaving no fallback plan. By Joseph Goldstein A big boost for the military, more aid for Ukraine, a ...

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...

Funding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage development and licensure of a pre-pandemic vaccine targeting the H5 influenza ...

Morningstar brands and products Company Portfolio ...

Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the company ...

The funding is through the Rapid Response Partnership Vehicle, a consortium funded by the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority.

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...